Clinical trial
Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both…
NCT00355654 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00355654 |
|---|---|
| Title | Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® |
| Official title | Safety and Immunogenicity of Booster Vaccination With PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed), Compared to Booster Vaccination With Infanrix® Hexa When Both Vaccines Are… |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infant, Healthy |
| Intervention type | Biological |
| Interventions | DT5aP-IPV-Hib 5-component Pertussis vaccine, DT3aP-HBs-IPV |
| Enrollment | 847 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Jul 24, 2006 |
| Last update posted | Jan 7, 2015 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: